| Synonyms: | |
| Status: | Phase 3 |
| Entry Type: | Antibody |
| Molecule Category: | UNKNOWN |
| UNII: | H9KH1GP3UU |
Pharmacology
| Action | Mechanism of Action | Reference |
|---|---|---|
| INHIBITOR | Complement C5 inhibitor |
Indications
| Mesh Heading | Maximum Phase | Mesh ID | Reference |
|---|---|---|---|
| Hemoglobinuria, Paroxysmal | 4 | D006457 | FDA |
| Guillain-Barre Syndrome | 3 | D020275 | ClinicalTrials |
| Atypical Hemolytic Uremic Syndrome | 3 | D065766 | ClinicalTrials |
| Hemoglobinuria | 3 | D006456 | ClinicalTrials |
| Anemia, Sickle Cell | 2 | D000755 | ClinicalTrials |
Cross References
| Resources | Reference |
|---|---|
| ChEMBL | CHEMBL4594316 |
| FDA SRS | H9KH1GP3UU |
CONTENTS